First-in-class steroid-toxicity outcome assessments licensed by argenx to support the development of novel steroid-sparing therapeutics for autoimmune diseases Boston, MA, USA, 19 November 2024: ...
Study will allow researchers to assess the outcomes of intravenous and oral glucocorticoid protocols in children Boston, MA, USA, 24 September 2024: Steritas LLC., a company dedicated to enhancing ...
Steritas is very pleased to have been named Startup of the Year during the 2023 SAMPS Awards. The annual SAMPS awards celebrate companies that are doing important work in the life science and applied ...
John H. Stone, MD MPH & Martha N. Stone will attend ACR Convergence 2023, the world's premier rheumatology meeting.
Glucocorticoids can do a lot of harm over time. In this podcast episode, John Stone, MD, MPH, walks us through the Glucocorticoid Toxicity Index, a validated tool to measure steroid toxicity over ...